Your browser doesn't support javascript.
loading
Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration.
Chun, Hye-Jung E; Johann, Pascal D; Milne, Katy; Zapatka, Marc; Buellesbach, Annette; Ishaque, Naveed; Iskar, Murat; Erkek, Serap; Wei, Lisa; Tessier-Cloutier, Basile; Lever, Jake; Titmuss, Emma; Topham, James T; Bowlby, Reanne; Chuah, Eric; Mungall, Karen L; Ma, Yussanne; Mungall, Andrew J; Moore, Richard A; Taylor, Michael D; Gerhard, Daniela S; Jones, Steven J M; Korshunov, Andrey; Gessler, Manfred; Kerl, Kornelius; Hasselblatt, Martin; Frühwald, Michael C; Perlman, Elizabeth J; Nelson, Brad H; Pfister, Stefan M; Marra, Marco A; Kool, Marcel.
Affiliation
  • Chun HE; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V7Z 1L3, Canada.
  • Johann PD; Hopp Children's Cancer Center, Heidelberg 69120, Germany; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg 69120, Germany; Department of Pediatric Hematology and Oncology, University Hospital Heidelberg
  • Milne K; Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada.
  • Zapatka M; Department of Molecular Genetics, DKFZ, Heidelberg 69120, Germany.
  • Buellesbach A; Hopp Children's Cancer Center, Heidelberg 69120, Germany; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg 69120, Germany; Department of Pediatric Hematology and Oncology, University Hospital Heidelberg
  • Ishaque N; Center for Digital Health, Berlin Institute of Health and Charité-Universitätsmedizin Berlin, Berlin 10117, Germany; Heidelberg Center for Personalized Oncology, DKFZ, Heidelberg 69120, Germany.
  • Iskar M; Department of Molecular Genetics, DKFZ, Heidelberg 69120, Germany.
  • Erkek S; Hopp Children's Cancer Center, Heidelberg 69120, Germany.
  • Wei L; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V7Z 1L3, Canada.
  • Tessier-Cloutier B; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6H 3N1, Canada.
  • Lever J; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V7Z 1L3, Canada.
  • Titmuss E; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V7Z 1L3, Canada.
  • Topham JT; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V7Z 1L3, Canada.
  • Bowlby R; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V7Z 1L3, Canada.
  • Chuah E; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V7Z 1L3, Canada.
  • Mungall KL; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V7Z 1L3, Canada.
  • Ma Y; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V7Z 1L3, Canada.
  • Mungall AJ; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V7Z 1L3, Canada.
  • Moore RA; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V7Z 1L3, Canada.
  • Taylor MD; Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
  • Gerhard DS; Office of Cancer Genomics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Jones SJM; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V7Z 1L3, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, BC V6H 3N1, Canada.
  • Korshunov A; Hopp Children's Cancer Center, Heidelberg 69120, Germany.
  • Gessler M; Theodor-Boveri-Institute/Biocenter, Developmental Biochemistry; and Comprehensive Cancer Center Mainfranken, University of Wuerzburg, Wuerzburg 97074, Germany.
  • Kerl K; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster 48149, Germany.
  • Hasselblatt M; Institute of Neuropathology, University Hospital Muenster, Muenster 48149, Germany.
  • Frühwald MC; University Children's Hospital Augsburg, Swabian Children's Cancer Center, Augsburg 86156, Germany.
  • Perlman EJ; Department of Pathology and Laboratory Medicine, Lurie Children's Hospital, Northwestern University's Feinberg School of Medicine and Robert H. Lurie Cancer Center, Chicago, IL 60611, USA.
  • Nelson BH; Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, BC V6H 3N1, Canada; Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC V8P 3E6, Canada.
  • Pfister SM; Hopp Children's Cancer Center, Heidelberg 69120, Germany; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg 69120, Germany; Department of Pediatric Hematology and Oncology, University Hospital Heidelberg
  • Marra MA; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V7Z 1L3, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, BC V6H 3N1, Canada. Electronic address: mmarra@bcgsc.ca.
  • Kool M; Hopp Children's Cancer Center, Heidelberg 69120, Germany; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg 69120, Germany. Electronic address: m.kool@kitz-heidelberg.de.
Cell Rep ; 29(8): 2338-2354.e7, 2019 11 19.
Article in En | MEDLINE | ID: mdl-31708418
ABSTRACT
Extra-cranial malignant rhabdoid tumors (MRTs) and cranial atypical teratoid RTs (ATRTs) are heterogeneous pediatric cancers driven primarily by SMARCB1 loss. To understand the genome-wide molecular relationships between MRTs and ATRTs, we analyze multi-omics data from 140 MRTs and 161 ATRTs. We detect similarities between the MYC subgroup of ATRTs (ATRT-MYC) and extra-cranial MRTs, including global DNA hypomethylation and overexpression of HOX genes and genes involved in mesenchymal development, distinguishing them from other ATRT subgroups that express neural-like features. We identify five DNA methylation subgroups associated with anatomical sites and SMARCB1 mutation patterns. Groups 1, 3, and 4 exhibit cytotoxic T cell infiltration and expression of immune checkpoint regulators, consistent with a potential role for immunotherapy in rhabdoid tumor patients.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes, Cytotoxic / Rhabdoid Tumor Type of study: Diagnostic_studies / Prognostic_studies Limits: Child / Female / Humans / Male Language: En Journal: Cell Rep Year: 2019 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes, Cytotoxic / Rhabdoid Tumor Type of study: Diagnostic_studies / Prognostic_studies Limits: Child / Female / Humans / Male Language: En Journal: Cell Rep Year: 2019 Document type: Article Affiliation country: